Thursday, Apr 23, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | World | Covid Jabs For Kids Pfizer To Seek Approval In Sep

Covid jabs for kids: Pfizer to seek approval in Sep

By early next week, the company is expected to get FDA approval for emergency use of its vaccine in children 12 to 15 years old.

By Agencies
Updated On - 11 June 2021, 11:43 AM
Covid jabs for kids: Pfizer to seek approval in Sep
whatsapp facebook twitter telegram

Washington: Pharmaceutical major Pfizer will likely seek the US Food and Drug Administration’s emergency authorization to administer its coronavirus vaccine among children between the ages of 2 and 11 in September, the media reported.

By early next week, the company is expected to get FDA approval for emergency use of its vaccine in children 12 to 15 years old.


It is planning to apply for full approval of the vaccine for use in people from ages 16 to 85, this month, The New York Times reported. The pharma major will also have clinical trial data on the safety of its vaccine in pregnant women by early August.

The FDA is preparing to make Covid vaccines “accessible to additional, younger populations”, Jen Psaki, the White House press secretary, was quoted as saying at a news conference on Tuesday, the report said.

Currently, the Pfizer-BioNTech vaccine is given to adults under an emergency use authorization that the companies received in December. Obtaining full FDA approval will allow it to market the vaccine directly to consumers.

“Full approval is a welcome indicator of the continued safety and efficacy of the Pfizer vaccine,” Saskia Popescu, an infectious disease epidemiologist at George Mason University, was quoted as saying.

Earlier in March, results of a clinical trial led by the companies showed that the Pfizer-BioNTech coronavirus vaccine is extremely effective in young adolescents, even more than in adults. The children produced strong antibody responses and experienced no serious side effects.

Vaccinating adolescents may also be key to boost immunity levels in the general population and thus reduce the number of hospitalisation and death.

A full approval may also make it easier for companies, government agencies, schools to get vaccinated and the jabs will stay in the market, even after the end of the pandemic, the report said.

  • Follow Us :
  • Tags
  • Coronavirus
  • emergency authorization
  • Pfizer
  • Pharmaceutical

Related News

  • India, US begin crucial trade talks

    India, US begin crucial trade talks

  • Trump says Cuba ‘will be next’ to collapse, signals openness to oil shipments

    Trump says Cuba ‘will be next’ to collapse, signals openness to oil shipments

  • Bill Clinton says he ‘did nothing wrong’ with Epstein as he faces grilling over their relationship

    Bill Clinton says he ‘did nothing wrong’ with Epstein as he faces grilling over their relationship

  • Hillary Clinton testifies she has no information on Epstein’s crimes and doesn’t recall meeting him

    Hillary Clinton testifies she has no information on Epstein’s crimes and doesn’t recall meeting him

Latest News

  • Lucknow suffers embarrasing 40-run loss against Rajasthan Royals

    2 hours ago
  • Opinion: Vishwa Guru vision must begin at home

    2 hours ago
  • DMK-Congress alliance vows to protect Tamil identity, says Rahul Gandhi

    2 hours ago
  • Editorial: Tim Cook leaves an enduring legacy

    2 hours ago
  • Delhi High Court holds YouTuber guilty of criminal contempt

    3 hours ago
  • TMC minister Bratya Basu warns of detention camps if BJP wins Bengal

    3 hours ago
  • Vendor, not SPG officer: Truth behind Modi’s Jhargram Jhalmuri stop

    3 hours ago
  • EC issues show cause notice to Kharge over ‘terrorist’ jibe at PM Modi

    3 hours ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

.